73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study may explain why once-promising cancer drugs failed

Study may explain why once-promising cancer drugs failed

by Duke UniversityInvading cells (green) in the lab wormC. elegans(purple) can change their tactics to get around cancer drugs called MMP inhibitors and trespass into other tissues. T

Study may explain why once-promising cancer drugs failed

by Duke UniversityInvading cells (green) in the lab wormC. elegans(purple) can change their tactics to get around cancer drugs called MMP inhibitors and trespass into other tissues. T
Tumor resistance is promoted by anti-cancer protein

Tumor resistance is promoted by anti-cancer protein

by Champalimaud Centre for the UnknownCredit: CC0 Public DomainLack of oxygen, or hypoxia, is a biological stressor that occurs under various conditions such as wound healing and stroke. To rescue the

Tumor resistance is promoted by anti-cancer protein

by Champalimaud Centre for the UnknownCredit: CC0 Public DomainLack of oxygen, or hypoxia, is a biological stressor that occurs under various conditions such as wound healing and stroke. To rescue the
New technique adds to the expanding suite of TAPS capabilities

New technique adds to the expanding suite of TAPS capabilities

byLudwig Cancer ResearchDevelopment of wglrTAPS. (A) Schematic representation of the wglrTAPS. (B) Sequence length distribution of wglrTAPS HiFi read. (C) Conversion rate of wglrTAPS at methylat

New technique adds to the expanding suite of TAPS capabilities

byLudwig Cancer ResearchDevelopment of wglrTAPS. (A) Schematic representation of the wglrTAPS. (B) Sequence length distribution of wglrTAPS HiFi read. (C) Conversion rate of wglrTAPS at methylat
Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l
Microbial signature of colorectal cancer-associated mutations identified

Microbial signature of colorectal cancer-associated mutations identified

by American Society for MicrobiologyCredit: CC0 Public DomainFor about 40% of people diagnosed with colorectal cancer (CRC), the tumor carries a mutation in a gene called KRAS. Many of those muta

Microbial signature of colorectal cancer-associated mutations identified

by American Society for MicrobiologyCredit: CC0 Public DomainFor about 40% of people diagnosed with colorectal cancer (CRC), the tumor carries a mutation in a gene called KRAS. Many of those muta
Researchers identify mechanism of resistance to BRAF inhibitors in melanoma

Researchers identify mechanism of resistance to BRAF inhibitors in melanoma

by H. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Melanoma i

Researchers identify mechanism of resistance to BRAF inhibitors in melanoma

by H. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0Melanoma i
Study: Innovative pancreatic cancer treatment may rev up immune system

Study: Innovative pancreatic cancer treatment may rev up immune system

by University of Rochester Medical CenterImmune cells (orange) and blood vessels (green) inside a tumor. Credit: University of Rochester Medical CenterA University of Rochester Wilmot Cancer Inst

Study: Innovative pancreatic cancer treatment may rev up immune system

by University of Rochester Medical CenterImmune cells (orange) and blood vessels (green) inside a tumor. Credit: University of Rochester Medical CenterA University of Rochester Wilmot Cancer Inst
Fewer lymph node operations for breast cancer patients with new prediction models

Fewer lymph node operations for breast cancer patients with new prediction models

by Lund UniversityCredit: MostphotosIn recently published studies, researchers at Lund University and Skåne University Hospital in Sweden have produced new prediction models for improved personal

Fewer lymph node operations for breast cancer patients with new prediction models

by Lund UniversityCredit: MostphotosIn recently published studies, researchers at Lund University and Skåne University Hospital in Sweden have produced new prediction models for improved personal
Occupational health study links air pollution and cancer

Occupational health study links air pollution and cancer

by University of StirlingCredit: CC0 Public DomainUniversity of Stirling experts have discovered new evidence of the link between air pollution and cancer as part of a new occupational health stu

Occupational health study links air pollution and cancer

by University of StirlingCredit: CC0 Public DomainUniversity of Stirling experts have discovered new evidence of the link between air pollution and cancer as part of a new occupational health stu
A step toward understanding gastric cancer

A step toward understanding gastric cancer

by Sanjay Mishra,Vanderbilt UniversityHistopathology of Helicobacter pylori infection in a gastric foveolar pit demonstrated in endoscopic gastric biopsy. Credit: Wikipedia.Helicobacter pylori&n

A step toward understanding gastric cancer

by Sanjay Mishra,Vanderbilt UniversityHistopathology of Helicobacter pylori infection in a gastric foveolar pit demonstrated in endoscopic gastric biopsy. Credit: Wikipedia.Helicobacter pylori&n
Study reveals pathways for aggressive prostate cancer subtype

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati

Study reveals pathways for aggressive prostate cancer subtype

by Vanderbilt University Medical CenterScRNAseq of ICC/IDC-enriched and benign-enriched prostate. a Schematic of scRNAseq protocol of ICC/IDC-enriched and benign-enriched prostate. b Representati
Research advances to better target debilitating effects of cachexia syndrome

Research advances to better target debilitating effects of cachexia syndrome

by Medical University of South CarolinaAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA study published inCell ReportsAug.

Research advances to better target debilitating effects of cachexia syndrome

by Medical University of South CarolinaAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA study published inCell ReportsAug.